CCS
DMTK

Concentric Capital Strategies’s DermTech, Inc. Common Stock DMTK Stock Holding History

Concentric Capital Strategies’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,800
Closed -$276K – 185
2022
Q1 		$276K Buy
+18,800
New +$252K 0.09% 135

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Concentric Capital Strategies's DMTK Position: Q2 2022 in Review

Concentric Capital Strategies sold out of DermTech, Inc. Common Stock (DMTK) in Q2 2022, closing a stake of 18,800 shares — an estimated $276K sold.

Concentric Capital Strategies first reported a position in DMTK in Q1 2022 and held it in 1 quarter. The position peaked at $276K in Q1 2022. 134 funds tracked by Wall St. Rank hold DMTK as of Q2 2022.

  • Concentric Capital Strategies reported no remaining DermTech, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Concentric Capital Strategies sold 18,800 DermTech, Inc. Common Stock shares in Q2 2022, an estimated $276K.
  • Concentric Capital Strategies first reported a position in DermTech, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Concentric Capital Strategies's DermTech, Inc. Common Stock position peaked at $276K in Q1 2022.
  • 134 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q2 2022.

Based on Concentric Capital Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.